Form 4 for LQDA Liquidia Corp
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001104659-25-056855 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-04 | LQDA | Saggar Rajeev | Chief Medical Off | S - Sale+OE | $16.97 | -7,597 | 273.2K | -3% | -$128.9K |
| D | 2025-06-05 | 2025-06-03 | LQDA | Saggar Rajeev | Chief Medical Off | M - OptEx | — | +17.7K | 280.8K | +7% | — |
| D | 2025-06-05 | 2025-06-03 | LQDA | Saggar Rajeev | Chief Medical Off | M - OptEx | $0.00 | -17.7K | 38.8K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | S | D | 7,597 | $16.97 | 273,209 | D | — | — | (F5) These shares were sold to cover taxes associated with the settlement of PSUs that were initially granted to the Reporting Person on January 11, 2024. (F3) Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-06-03 | M | A | 17,654 | — | 280,806 | D | — | — | (F2) On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. Of those PSUs, a total of 17,654 have vested through June 3, 2025. (F1) Performance stock units ("PSUs") convert into common stock on a one-for-one basis. (F3) Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 3 | Derivative | Performance Stock Units | 2025-06-03 | M | D | 17,654 | $0.00 | 38,838 | D | — · — to — | 17,654 Common Stock | (F1) Performance stock units ("PSUs") convert into common stock on a one-for-one basis. |